Oxindole-based intraocular pressure reducing agents

Bioorganic & Medicinal Chemistry Letters
2017.0

Abstract

The study represents the new findings at the crossroads of chemistry and medicine, particularly between medicinal and organic chemistry and ophthalmology. In this work we describe how the chemical reactivity of indolinone scaffold may be used to create small molecule ligands with strong biological response comparable with and larger than that of endogenous hormone. The synthesis of oxindole-based melatonin and 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT) analogues was proposed and their ability to influence intraocular pressure (IOP) was studied in vivo. Time-dependent study revealed the prolonged effect (more than 6h) of the lead-compound. This effect in combination with high IOP reducing effect (41±6%) in low concentrations of the active compound (0.1wt%) and with high water solubility represents a great potential of low-cost oxindole derivatives as potent antiglaucoma agents.

Knowledge Graph

Similar Paper

Oxindole-based intraocular pressure reducing agents
Bioorganic & Medicinal Chemistry Letters 2017.0
The rational design of novel 5-amino-2-oxindole derivatives with antiglaucomic activity
Bioorganic & Medicinal Chemistry Letters 2023.0
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit
Journal of Medicinal Chemistry 2018.0
Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma
Bioorganic & Medicinal Chemistry Letters 2009.0
1-((S)-2-Aminopropyl)-1H-indazol-6-ol:  A Potent Peripherally Acting 5-HT<sub>2</sub>Receptor Agonist with Ocular Hypotensive Activity
Journal of Medicinal Chemistry 2006.0
2-MeS-β,γ-CCl<sub>2</sub>-ATP is a Potent Agent for Reducing Intraocular Pressure
Journal of Medicinal Chemistry 2010.0
A Novel and Selective 5-HT<sub>2</sub> Receptor Agonist with Ocular Hypotensive Activity:  (S)-(+)-1-(2-Aminopropyl)-8,9-dihydropyrano[3,2-e]indole
Journal of Medicinal Chemistry 2003.0
Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Synthesis and Evaluation of 2-[(5-Methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a Potent, Peripherally Acting α<sub>2</sub>Adrenoceptor Agonist
Journal of Medicinal Chemistry 1996.0
Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for .beta.-adrenergic blocking agents
Journal of Medicinal Chemistry 1988.0